In the present study, BRCA1/2 pathogenic variants were not detected in a small group of familial pancreatic cancer patients (n = 4), in agreement with other small studies from China (n = 9) [12] and Spain (n = 43) [48] and a large study from Italy (n = 282) [28]. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.